Given the rarity of CNS lymphomas in ZAP70-deficient patients, further studies and case reports are needed to elucidate the association with CNS tumors, clarify underlying genetic and immunologic risk factors, and guide the development of targeted therapies. Here, ZAP70 is linked to primary central nervous system lymphoma.